
Med School Research Scientist Timsy Uppal and Engineering post-doctoral researcher Bhaskar Vadlamani testing the SARS-CoV-2 nanosensor.
University of Nevada, Reno engineers and virologists team up for novel approach
Rapid detection of the SARS-CoV-2 virus, in about 30 seconds following the test, has had successful preliminary results in Mano Misra’s lab at the University of Nevada, Reno. The test uses a nanotube-based electrochemical biosensor, a similar technology that Misra has used in the past for detecting tuberculosis and colorectal cancer as well as detection of biomarkers for food safety.
Professor Misra, in the University’s College of Engineering Chemical and Materials Department, has been working on nano-sensors for 10 years. He has expertise in detecting a specific biomarker in tuberculosis patients’ breath using a metal functionalized nano sensor.
“I thought that similar technology can be used to detect the SARS-CoV-2 virus, which is a folded protein,” Misra said. “This is Point of Care testing to assess the exposure to COVID-19. We do not need a laboratory setting or trained health care workers to administer the test. Electrochemical biosensors are advantageous for sensing purposes as they are sensitive, accurate and simple.”
The test does not require a blood sample, it is run using a nasal swab or even exhaled breath, which has biomarkers of COVID-19. Misra and his team have successfully demonstrated a simple, inexpensive, rapid and non-invasive diagnostic platform that has the potential to effectively detect the SARS-CoV-2 virus.
The team includes Associate Professor Subhash Verma, virologist, and Research Scientist Timsy Uppal at the University’s School of Medicine, and Misra’s post-doctoral researcher Bhaskar Vadlamani.
“Our role on this project is to provide viral material to be used for detection by the nanomaterial sensor developed by Mano,” Verma said. “Mano contacted me back in April or May and asked whether we can collaborate to develop a test to detect SARS-CoV-2 infection by analyzing patients’ breath. That’s where we came in, to provide biological material and started with providing the surface protein of the virus, which can be used for detecting the presence of the virus.”
Verma, an expert on SARS-CoV-2, synthesized and prepared the antigenic protein of COVID-19 virus in his laboratory, SARS-CoV-2 receptor binding domain protein, for the preliminary testing and determining the sensitivity of our nano sensor. Synthesizing and purification of viral proteins is usual and routine work in a virology laboratory.
“Our lab is a virology laboratory, which works on different viruses, and we have been working on SARS-CoV-2 from the beginning of the outbreak,” he said. “Our genomics and diagnostic group have been sequencing the SARS-CoV-2 from the nasal swabs of COVID-19 patients of the state of Nevada to determine mutational changes in the virus while SARS-CoV-2 circulates in our population.”
The team developed co-metal functionalized nanotubes as a sensing material for electrochemical detection of the protein. They confirmed the biosensor’s potential for clinical application by directly analyzing the RBD of the Spike glycoprotein on the sensor.
The team plans to move to the next step of sensor validation on the actual COVID-19 patients swabs stored in the Viral Transport Medium (VTM) and have applied for funding to develop a specific and inexpensive point-of-care sensor for a rapid detection of COVID-19 virus in saliva or breath of infected individuals.
“A rapid and accurate testing method is critical to establishing a rigorous testing protocol to allow us to continue our operations while maximizing the safety of our students, faculty and staff,” College of Engineering Dean Manos Maragakis said. “I am excited and proud that a research team led by faculty from the College of Engineering in collaboration with faculty from our Medical School are leading such a promising and innovative effort. I am looking forward to the outcome.”
The developed approach also has the potential for diagnosis of other respiratory viral diseases by identifying appropriate metallic elements to functionalize nanotubes.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Covid-19 detection
- Canada's Sick Leave Policies Fuelling COVID-19 Transmission, Doctors Sayon January 12, 2021 at 1:49 pm
As Canadian provinces struggle to contain rising COVID-19 infections, a lack of adequate paid sick leave for front-line workers is fuelling transmission, doctors and advocates say. One morning last ...
- Did Rapid Antigen Tests Help Fuel After-Christmas Surge Of COVID-19?on January 12, 2021 at 12:59 pm
Despite their good intentions, some people who tested negative for the coronavirus using a rapid antigen test before visiting friends and family over Christmas may have developed a false sense of ...
- 'Dentists Should Be Performing Covid-19 Saliva Tests On Patients To Help Combat The Virus' Says Nationally-Renowned Dentiston January 12, 2021 at 11:35 am
BEVERLY HILLS, Calif., /PRNewswire/ -- Next time you go to get your teeth cleaned, imagine spitting into a vial and getting rapid Covid-19 results from your dentist. That scenario is now being ...
- More infectious COVID-19 variant now seen in nine stateson January 12, 2021 at 10:42 am
The more contagious coronavirus variant that has brought Britain to its knees in recent weeks is showing signs that it is spreading widely throughout the United States, health officials and experts ...
- Ortho's VITROS® SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the Firston January 12, 2021 at 10:30 am
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that its VITROS® SARS-CoV-2 Antigen Test, designed ...
Go deeper with Google Headlines on:
Covid-19 detection
Go deeper with Bing News on:
SARS-CoV-2 detection
- GT Molecular launches two highly sensitive tests for the dangerous UK Variant of SARS-CoV-2 (B.1.1.7)on January 12, 2021 at 12:56 pm
GT Molecular, a rapidly expanding molecular diagnostics biotech, has launched two highly sensitive tests for the dangerous UK Variant of SARS-CoV-2 (B.1.1.7). These novel assays build upon GT ...
- Ortho's VITROS® SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the Firston January 12, 2021 at 10:30 am
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that its VITROS® SARS-CoV-2 Antigen Test, designed ...
- FDA Issues Emergency Use Authorization for MatMaCorp's COVID-19 2SF RNA Test for the Detection of SARS-CoV-2on January 12, 2021 at 10:00 am
LINCOLN, Neb.--(BUSINESS WIRE)--MatMaCorp (Materials and Machines Corporation), a developer of comprehensive molecular diagnostic systems, today announced that the U.S. Food and Drug Administration ...
- New England Biolabs Expands its Luna® Portfolio with the SARS-CoV-2 RT-qPCR Multiplex Assay Kiton January 12, 2021 at 8:00 am
PRNewswire/ -- New England Biolabs® (NEB®) today announced the launch of its Luna®SARS-CoV-2 RT-qPCR Multiplex Assay Kit for real-time detection of ...
- T2 Biosystems T2SARS-CoV-2™ Panel Proves Effective Amid Global Rise in Variants of the SARS-CoV-2 Virus Nasdaq:TTOOon January 12, 2021 at 7:41 am
Panel can detect multiple variants of the SARS-CoV-2 virus, including those most recently identified in the United Kingdom, South Africa, and the U.S. LEXINGTON, Mass., Jan. 11, 2021 (GLOBE ...